Test Code LGB3S Globotriaosylsphingosine, Serum
Reporting Name
Lyso-GB3, SPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Diagnosis and monitoring of Fabry disease
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Ordering Guidance
This test should not be used to determine carrier status. Order FABRZ / Fabry Disease, Full Gene Analysis, Varies for carrier testing.
Necessary Information
1. Patient's age is required.
2. Reason for testing is required.
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Specimen Type
SerumSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Frozen (preferred) | 90 days | |
Refrigerated | 48 hours |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | Reject |
Gross icterus | OK |
Reference Values
≤1.0 ng/mL
Interpretation
Elevation of globotriaosylsphingosine is diagnostic for Fabry disease.
Day(s) Performed
Thursday
Report Available
8 to 14 daysTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82542
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
LGB3S | Lyso-GB3, S | 90234-6 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
BG708 | Reason for Referral | 42349-1 |
65532 | Lyso-GB3, S | 90234-6 |
113176 | Interpretation (LGB3S) | 59462-2 |
113177 | Reviewed By | 18771-6 |
Forms
1. Biochemical Genetics Patient Information (T602)
2. If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.